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Abstract: Background: The aim of the study was to compare the quality of life (QoL) of cancer survivors
with a control group of healthy subjects before, during, and after the orthodontic treatment. Methods:
Consecutive cancer survivors (40 people) who were looking for orthodontic treatment between 2008
and 2015 were enrolled into the study. Healthy orthodontic patients matched for age (±4 years),
sex, and malocclusion served as controls. The 14-item version of the Oral Health Impact Profile was
used to assess the effect of orthodontic treatment on QoL before, during, and after the orthodontic
treatment. Results: There were no significant differences between both groups regarding the cast
model, cephalometric analysis, and photographic documentation analysis. There was a significant
worsening of QoL after the onset of the orthodontic treatment with a significant improvement after
the treatment. Male cancer survivor patients reported significantly lower QoL during the treatment
time, which was not observed in the male control group. Conclusions: The outcome of orthodontic
treatment in cancer survivors did not differ from the healthy orthodontic patients. The orthodontic
treatment had an impact on the oral health quality of life both in the cancer and the control groups
with a significantly higher impact in male cancer survivor patients.
Keywords: quality of life; oral health-related quality of life; orthodontic treatment; cancer survivors
1. Introduction
The major cause of death among children worldwide is cancer [1,2]. The total number of childhood
cancers constitutes approximately 2–3% of all cancers. Cancer occurs in more than 300,000 children
every year worldwide. Prompt diagnosis, referral, and multidisciplinary care play significant role in
successful cancer treatment [3]. Three most common childhood malignancies are: leukemias, brain
tumors, and lymphomas [1,4]. Most of the childhood cancers may be cured with high survival rates,
especially in high-income countries [3]. Low-income and middle-income countries are unfortunately
characterized by diminished survival rates, mostly because of: misdiagnosis, inadequate access to
treatment, death from toxicity, treatment abandonment, and relapse [5]. Despite the fact that the
pediatric oncology is expensive, childhood cancer treatment is undoubtedly cost effective [6]. World
Health Organization launched, in 2018, Global Initiative for Childhood Cancer, which aims to ensure
the survival of at least 60% of children with cancer by 2030 [3].
Contemporary advances in cancer treatment resulted in 80% overall survival of young patients
suffering from cancer. It is estimated that, at present, 1/900 young adults had undergone a successful
cancer treatment in their childhood [7]. Therefore, the number of cancer survivors looking for
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orthodontic consultation and treatment might be growing. The orthodontic treatment in postoncological
patients is expected to be much more complicated, because up to 50% of those patients have experienced
short- and long-term adverse effects of both systemic and local oncologic treatment [8].
Radiotherapy may lead to oral mucositis, dysfunctional taste, malnutrition, and radiation
caries [9]. Moreover, growing patients treated with chemotherapy and radiotherapy present the
below mentioned side effects of oncological treatment: viscerocranium growth disorders, reduction
in size of the alveolar processes of the maxilla and mandible, temporomandibular joint disorders
(TMD), reduction of the length of pubertal growth, inhibition of tooth development, microdontia,
hypodontia/oligodontia/anodontia, demineralization of the hard tissues of the teeth, shortening of dental
roots—V-shaped roots, premature closing of root canal apices, root resorption, and tooth mobility [9,10].
According to the American Academy of Pediatric Dentistry (AAPD), there are three major
objectives of a dental/oral examination after the end of oncological treatment (exclusive of HCT,
hematopoietic cell transplantation). These are: to maintain optimal oral health, to reinforce to the
patient/parents the importance of optimal oral and dental care for life, and to address and/or treat any
dental issues that may arise as a result of the long-term effects of cancer therapy [11,12]. AAPD also
presented a few suggestions regarding the orthodontic treatment after the oncological treatment has
been finished. Orthodontic treatment may be commenced after at least 2 years of survival without any
oncological disease and only in patients who are no longer taking immunosuppressive drugs. It is
suggested to use appliances that minimize the risk of root resorption, to use lighter forces, to terminate
treatment earlier than normal, to choose the simplest method for the treatment needs, and not to treat
the lower jaw [11,12].
Although, the clinical examination of oral health is very important in the process of proper
diagnosis and the accurate treatment planning, it does not include any functional or psychosocial
aspects regarding the oral health. Therefore, the Oral Health-Related Quality of Life (OHRQoL) has
been invented [13,14]. Among different indices meeting the criteria for OHRQoL, one of the most often
used is the 14-item Oral Health Impact Profile (OHIP-14) [13].
The quality of life (QoL) of orthodontic patients has gained more attention in recent years.
It is a multidimensional concept that includes subjectively perceived physical, psychological, and
social functions, as well as a sense of subjective well-being in the areas of life that are important to
individuals [15]. This assessment was introduced for better understanding of the impact of oral health
on the daily lives of patients. However, the results of orthodontic treatment of cancer survivors and its
influence on their quality of life remain unknown.
Therefore, the aim of the study was to compare the quality of life of cancer survivors with a
control group of healthy subjects before, during, and after the orthodontic treatment.
2. Materials and Methods
2.1. Study Population
The study was held since January 2008 till December 2015. The study sample consisted of 40
consecutively selected patients (14 male and 26 female) with the history of childhood cancer who came
to the specialist orthodontic practice, looking for orthodontic treatment. The median age of this group
was 19.4 (range 14–28 years). Primarily, the study included 46 patients with the history of childhood
cancer, but six patients were subsequently excluded from the study according to the exclusion criteria.
The exclusion criteria were: previous orthodontic treatment, severe dentofacial deformities, such as
cleft lip and palate, poor periodontal health, mental health disorders, including: anxiety disorders,
depression, bipolar disorder, schizophrenia, and patients who did not agree to take part into the study.
The control group of 40 patients (14 male and 26 female) with a median age of 19.2 (range
14–28 years) was selected by matching age (±4 years), gender, and malocclusion. Healthy patients
matched for age (±4 years), gender, and malocclusion served as control group.
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We calculated the required sample size considering two equally numbered groups of patients, 90%
of power, type I error 0.05, to detect 20% difference in OHIP-14 should include 175 patients. However,
after analyzing 40 oncologic and control patients we did not see any difference between the groups.
All of the patients were recruited and treated in the same specialist orthodontic private practice in
Krakow (Poland).
Figure 1 presents the flow chart of participation. The baseline characteristics of cancer survivors’
and control group are presented in Table 1.
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Number of patients (n) (female/male ratio) 40 (26/14) 40 (26/14) 1.000
Median age (range) (years) 19.4 (14–28) 19.2 (14–28) 0.889
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Skeletal class II: 26 patients each group
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Skeletal class III: 5 patients each group
1.000
a Mann–Whitney U test.
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Leukemia 22 3.8 ± 1.3 9.5 ± 4.6 28 0
Neuroblastoma 3 0.7 ± 0.4 5.3 ± 1.1 4 0
Soft tissue sarcoma 3 2.2 ± 1.76 7.2 ± 2.0 4 1
Non-Hodgkin’s lymphoma 6 4.7 ± 2.1 8.0 ± 4.2 8 1
Wilms tumor 6 3.8 ± 2.2 6.1 ± 3.3 8 0
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The study was approved by the Medical Board Ethical Committee (50/KBL/OIL/2010) and was
conducted with the ethical principles of the World Medical Association Declaration of Helsinki. All
of the patients received and signed informed consent. Parents received a letter describing the study
protocol and requesting consent for their children to participate in the study.
2.2. Study Protocol
All the treatment and diagnostic records were prospectively collected in the database, according
to the recognized clinical practice guidelines. All of the patients were treated orthodontically with
fixed orthodontic appliances in both jaws.
The primary endpoint was to assess the quality of life of the patients. The secondary endpoints
included: establishing a normal occlusion [16] (defined as class I molar and canine relations on both
sides, normal occlusal contacts, midline symmetry, normal overjet and overbite, levelling and aligning
the teeth within dental arches, improving/maintaining the aesthetics of the face and smile (assessed
using the weighted Peer Assessment Rating–wPAR–Index), and avoiding complications during and
after the treatment, defined as any event occurring in the follow-up period, which would require the
treatment not routinely applied in this particular period).
In both groups, there were no aberrations in the root development diagnosed in the pantomographic
X-ray before the onset of the orthodontic treatment.
The process of orthodontic diagnosis was performed by two independent certified specialists
of orthodontics, whereas the orthodontic treatment was performed by the certified specialist of
orthodontics with 18 years of experience in the field of orthodontics. All of the patients were treated
orthodontically with the vestibular fixed appliances with the 0.022-in bracket slot and the MBT
prescription. In particular, 90% of the examined patients were treated with no extractions, whereas the
remaining 10% of the patients were treated with extractions, mostly because of severe crowding in
lower dental arch. All of the cases were treated with sliding mechanics. The anchorage was increased
by the usage of Goshgarian transpalatal bar and intermaxillary elastics. None of the treated cases
required the usage of skeletal anchorage devices, including microscrews or miniplates.
All participants filled in the 14-item version of the Oral Health Impact Profile (OHIP-14), which
is well-known and valid oral health-related quality of life indicator [15]. It was used to define seven
conceptual dimensions of impact including: functional limitation (e.g., troubles while pronouncing
words and dysfunctional taste), physical pain (e.g., painful aching and problems with eating),
psychological discomfort (e.g., self-consciousness and tension), physical disability (e.g., unsatisfactory
diet and interrupted meals), psychological disability (e.g., difficulty to relax and feeling of being
embarrassed), social disability (e.g., irritability with others and irritability doing work), and handicap
(e.g., unsatisfactory life and problems to function normally). Patients’ responses were rated on the
5-point Likert scale and were coded as: 0 (= never), 1 (= hardly ever), 2 (= occasionally), 3 (= fairly often),
and 4 (= very often/every day) [13]. Table 3 presents the list of questions in the OHIP-14 Questionnaire.
Two different methods of scoring were used: the OHIP-14 additive method, in which the total
score was calculated summing up the values for the 14 items (the total score ranges from 0 to 56), and
OHIP-14 simple count, in which the total score was calculated summing up the number of domains
reported as occasionally or more frequently (the number of domains ranges from 0 to 7). The OHIP-14
was evaluated before treatment, 2 weeks and 3 months after the onset of the treatment, and after the
end of the treatment.
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Table 3. The list of questions in the 14-item Oral Health Impact Profile (OHIP-14) Questionnaire [17].
The List of Questions in the OHIP-14 Questionnaire
Functional Limitation
1. Have you had trouble pronouncing any words because of problems with your teeth or mouth?
2. Have you felt that your sense of taste has worsened because of problems with your teeth or mouth?
Physical Pain
3. Have you had painful aching in your mouth?
4. Have you found it uncomfortable to eat any foods because of problems with your teeth or mouth?
Psychological Discomfort
5. Have you been self-conscious because of your teeth or mouth?
6. Have you felt tense because of problems with your teeth or mouth?
Physical Disability
7. Has been your diet been unsatisfactory because of problems with your teeth of mouth?
8. Have you had to interrupt meals because of problems with your teeth or mouth?
Psychological Disability
9. Have you found it difficult to relax because of problems with your teeth or mouth?
10. Have you been a bit embarrassed because of problems with your teeth or mouth?
Social Disability
11. Have you been a bit irritable with other people because of problems with your teeth or mouth?
12. Have you had difficulty doing your usual jobs because of problems with your teeth or mouth?
Handicap
13. Have you felt that life in general was less satisfying because of problems with your teeth or mouth?
14. Have you been totally unable to function because of problems with your teeth or mouth?
2.3. Statistical Analysis
The data were analyzed using Statistica 12.0 software (StatSoft Inc., Tulsa, OK, USA). No data was
missing. Categorical variables were described as percentages of the total population, while continuous
variables were reported as median and range. The Pearson’s chi-square or Fisher’s exact tests were
applied, The Shapiro–Wilk and the Kolmogorov–Smirnov tests, with the Lilliefors correction, were
used to confirm the normality of the distribution of the continuous variables. The unpaired Student t
test or the nonparametric Mann–Whitney U tests were used for comparisons. The ANOVA test with
repeated responses was used to assess differences in OHIP-14 across groups and time of treatment.
Statistical significance was established at the level of p ≤ 0.05.
3. Results
This clinical trial was characterized by 81% statistical power, assuming two groups of 40 people
each and RMSSE (root-mean square standardized effect) value 0.46.
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The majority of the cancer survivors were diagnosed with leukemia (54%), followed by
non-Hodgkin’s lymphoma (15.4%), Wilms tumor (15.4%), neuroblastoma (7.7%), and soft tissue
sarcoma (7.7%). The median time from oncologic treatment was 9 years with a range from 6 to 12 years.
Due to matching process, 26 patients (65%) had skeletal class II, 9 patients (22.5%) had skeletal
class I, and 5 patients (12.5%) had skeletal class III, both in the cancer survivors’ and the control group.
The average time of follow-up was 18 months. The average time of treatment in the cancer
survivors’ group was significantly shorter than in the control group (12.5 vs. 18.0 months; p < 0.01).
There were no significant differences in the outcomes of the orthodontic treatment achieved in both
groups, assessed using study models, cephalometric analysis, and photographic documentation.
Appropriate ideal occlusion was achieved in all patients with mean weighted PAR scores of 4.2–6.0 in
both study groups. The reduction in the weighed PAR score was on average 81.7% and 80.5% in the
control and cancer survivors’ group, respectively.
Ten cancer survivor patients and 2 patients from the control group had their orthodontic appliances
temporarily removed to perform magnetic resonance imaging (MRI). Eight patients with ceramic
brackets had MRI examination without removing the appliances. Significantly more patients from the
cancer survivors’ group had oral mucositis (11 vs. 4; p < 0.05). Moreover, in the control group, there
were two patients allergic to nickel. Three patients from the cancer survivors’ group had some signs of
orthodontic root resorption (3 vs. 0; p < 0.05).
3.1. OHIP-14 Total Score
The orthodontic treatment had a statistically significant impact on the oral health-related quality of
life in both groups. The OHIP-14 mean total score was significantly higher in both groups after 2 weeks
(p < 0.001) and 3 months (p < 0.001) after the onset of the orthodontic treatment and significantly lower
after the orthodontic treatment (p < 0.001) in comparison to the pretreatment results. However, when
comparing both groups 2 weeks and 3 months after the onset of the orthodontic treatment, the cancer
survivors’ group had higher values of the mean OHIP-14 total score, but the differences were not
statistically significant.
Figure 2 presents the mean total score values of the OHIP-14 index before, during, and after the
orthodontic treatment in cancer survivors’ and control groups.
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Cancer Survivors’ Group Control Group





3.5 ± 3.9 1,2,3 3.7 ± 3.0 4,5,6
0.278(0–14) (0–9)
2 weeks after the onset of TX
8.2 ± 8.9 1 8 ± 5.0 4
0.159(0–32) (0–20)
3 months after the onset of TX
6.2 ± 7.9 2 6.2 ± 3.9 5
0.213(0–28) (0–15)
After TX
1.0 ± 2.5 3 0.6 ± 2.3 6
0.126(0–14) (0–12)
1–6 statistically significant differences with p < 0.001 (ANOVA); a Mann–Whitney U test; SD, standard deviation.
Table 5 shows the mean scores of the OHIP-14 index for individual domains observed before
the onset of the orthodontic treatment, 2 weeks after the onset of orthodontic treatment, 3 months
after the onset of orthodontic treatment, and after finishing the orthodontic treatment. The only
statistically significant differences between the examined groups referred to the psychological
discomfort. The psychological discomfort 2 weeks and 3 months after the onset of the treatment was
significantly higher in the cancer survivors’ group compared to the control group (p < 0.001).
Table 5. The mean OHIP-14 score for individual domains observed before, during, and after orthodontic
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1,2 statistically significant differences with p < 0.001 (unpaired Student t test).
Table 6 presents the probability values (p-values) describing the differences regarding the mean
OHIP-14 scores between different stages of orthodontic treatment (before treatment vs. 2 weeks after
the onset of the treatment, before treatment vs. 3 months after the onset of the treatment, and before
treatment and after the treatment) in each domain, independently for the cancer survivors’ and control
groups. The presented results indicate that orthodontic treatment had the highest impact on functional
limitation and physical pain in both groups. Statistical significance of the differences regarding the
mean OHIP-14 score in the domains psychological discomfort, physical disability, and psychological
disability was higher for the cancer survivors’ group. Moreover, orthodontic treatment had no impact
on social disability.
When it comes to gender differences, male comparing to female cancer survivor patients reported
a significantly lower quality of life during the treatment period (2 weeks and 3 months after the onset
of the orthodontic treatment), which was not seen in the male control group (2 weeks: 10.3 ± 10.2 vs.
6.3 ± 5.7; 3 months: 8.2 ± 8.9 vs. 4.3 ± 4.5; p < 0.05, respectively). These differences were not observed
before and after the treatment. Figure 3 presents the gender differences in the OHIP-14 total score
between the cancer survivors’ and the control groups.
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Table 6. The probability values (p-values) describing the differences regarding the mean OHIP-14
score between different stages of orthodontic treatment in each domain, independently for the cancer































































All p-values were measured using ANOVA; the cancer survivors’ group and the control group.
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index scored with the additive method.
3.2. OHIP-14 Simple Count
Analyzing the number of patients with impaired domains, there were two statistically significant
differences between the examined groups regarding only the psychological discomfort domain.
The number of cancer survivor patients who reported psychological discomfort 2 weeks (13 vs. 2,
p = 0.002) and 3 months (11 vs. 2, p = 0.006) after the onset of the orthodontic treatment was significantly
higher than the number of patients form control group. Table 7 presents the detailed number of
impaired domains in both groups the cancer survivors’ and the control ones.
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Before 6 (15.0%) 3 (7.5%) 0.289
2 weeks 13 (32.5%) 11 (27.5%) 0.716
3 months 11 (27.5%) 6 (15.0%) 0.172
After the treatment 2 (5.0%) 1 (2.5%) 0.556
4. Discussion
Contemporary oncologic treatment is predominantly multimodal and involves surgery,
chemotherapy, and radiotherapy. There are numerous studies showing the influence of these methods
of treatment on both the alveolar bone and the surrounding soft tissues, which results in growth
restriction, development of an asymmetry, impaired occlusal development, and dental and root
malformations [18–20]. The risk for these complications increases not only with the younger age of the
patient (particularly in children undergoing oncologic treatment below the age of 5 years) but also
with the exposure to high doses of chemotherapeutic agents and high dose radiotherapy [21].
This is the first study that prospectively assesses both the outcomes of the orthodontic treatment
and the patients’ quality of life before, during, and after the orthodontic treatment between the cancer
survivor and the control groups, which were perfectly matched for age, gender, and type of malocclusion.
According to our research, there were no statistically significant differences regarding the
orthodontic treatment outcomes between cancer survivors’ group and healthy subjects. We observed a
higher number of oral mucositis and root resorption in the cancer survivors’ group. However, early
detection of those complications could have prevented their long-term adverse effects. Oral mucositis
is a diffuse ulcerative lesion, associated with radiotherapy in the course of head and neck cancer
treatment [22]. According to Sonis [22], there is nearly 100% risk of oral mucositis development in the
standard chemoradiation protocols in the area of head and neck in patients who receive chemotherapy
and radiotherapy with cumulative radiation doses higher than 30 Gy.
Several methods have been developed to measure people’s oral health-related quality of life.
Hongxing et al. [13] compared the validity and reliability of two different indices: OHIP-14 and
the Oral Impact of Daily Performance (OIDP). According to the authors, although both indices had
reasonable validity and reliability, the OHIP-14 presented increased sensitivity towards less severe
impacts. Montero-Martin et al. [23] validated the usage of the OHIP-14 among adult Spanish people.
The authors concluded that the OHIP-14 was a precise, valid, and reliable index that can be used to
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assess quality of life related to oral health. Therefore, the OHIP-14 is one of the most commonly used
questionnaires. This index was proven to be reliable, sensitive to changes and showing adequate
cross-cultural consistency.
Andiappana et al. [15] noticed in their systematic review and meta-analysis regarding the
association between the presence of malocclusion and patients’ quality of life that there was a high level
of heterogeneity among the examined studies and the results varied between populations. Most of the
patients were nononcologic ones, who had been qualified for orthodontic treatment or for orthognathic
surgery. These studies revealed also that the patients with a malocclusion had a higher OHIP-14 total
score in comparison to those without malocclusion [15]. Until now, there has been no study reporting
the quality of life at the end of the active orthodontic treatment in postoncological treatment patients.
We have proven, that orthodontic treatment had an impact on the oral health quality of life in both
groups: the cancer survivors’ and the control ones, by decreasing the quality of life during the treatment
and increasing it after its completion. Moreover, the impact of orthodontic treatment on patients’
quality of life was significantly higher in male cancer survivor patients. Physical pain, psychological
discomfort, and psychological disability domains contributed most significantly to higher values of
the OHIP-14 index during the treatment. However, only psychological discomfort turned out to be
significantly different between the cancer survivors’ and control groups. An interesting finding from
our study is that cancer survivors’ male patients had a significantly worse quality of life during active
treatment in comparison to the male controls. This effect was not seen in female cancer survivor
patients. We can only hypothesize on the psychological influence of the previous disease history on
the current treatment. The long-term positive and negative effects of post-traumatic stress disorder in
childhood cancer survivors are well documented in the literature [24,25] and could be further studied
on a larger group using more detailed questionnaires or psychological consultations.
Johal et al. [26] also noticed that the orthodontic treatment with fixed appliances had a negative
impact on the OHIP-14 scores within the first 3 months after the onset of the orthodontic treatment.
The OHIP-14 values after first and third month of active orthodontic treatment were significantly
higher compared to the initial value of OHIP-14 index before treatment. Unlike, the authors found
that there were no statistically significant differences regarding the OHIP-14 values before and after
orthodontic treatment. However, most of the authors, who compared the OHIP-14 values before
and after orthodontic treatment, found that the patients’ quality of life had significantly improved
after orthodontic treatment [27–30]. Moreover, Zheng et al. [31] found that the positive impact of
orthodontic treatment on the patients’ quality of life depends on the type of malocclusion. According
to the authors, patients with class II benefitted the most from the space closure stage, whereas patients
with class I malocclusion benefitted the most from alignment and levelling of their teeth, which is
an initial stage of orthodontic treatment. Ni et al. [29] assessed the OHIP-14 in patients with skeletal
class III, who had been treated surgically. The authors found that during the decompensation phase
of orthodontic treatment, the patients’ quality of life had significantly decreased, whereas after the
surgical orthodontic treatment, it had been significantly improved. The same observations presented
Rezaei et al. [30].
There are researches which compared the OHIP-14 values between patients who had been
and had not been treated orthodontically. According to the authors [32,33], patients who had been
treated orthodontically had more positive oral health-related quality of life compared to the untreated
subjects with malocclusion. The authors stated that dental malocclusion had significant negative
impact on oral health-related quality of life. Kang et al. [34] also supported this thesis. Patients with
either malocclusion or under the orthodontic treatment presented higher OHIP-14 scores comparing
to the patients with normal occlusion or patients after the orthodontic treatment, who are in the
retention phase.
There are some limitations to our study. The study population is relatively small and consists of
cancer survivors treated for various malignancies, both solid tumors and hematologic malignancies.
Moreover, the regimen used for oncologic treatment varies between patients making any comparison
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of its influence difficult. Finally, different types of orthodontic treatment biomechanics could have had
an impact on patients’ quality of life, including different types of anchorage, usage of intermaxillary
elastics, or placing additional hooks on the archwire.
5. Conclusions
The outcomes of the orthodontic treatment achieved in cancer survivors’ group did not differ
significantly from the outcomes of the orthodontic treatment achieved in the group of healthy subjects.
The orthodontic treatment had an impact on the oral health-related quality of life in both groups:
the cancer survivors and the control group with a significantly higher impact on the male cancer
survivor patients. The assessment of the quality of life during orthodontic treatment allows better
understanding of patients’ needs and, therefore, better addressing the orthodontic care, particularly in
specific domains, especially in cancer survivor patients.
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